The latest closing stock price for CRISPR Therapeutics AG as of September 19, 2024 is 49.49.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,512 today, roughly 3 times their original investment - a 17.00% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 91.10, which is 84.1% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 37.55, which is 24.1% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 58.74.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,512 today, roughly 3 times their original investment - a 17.00% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 91.10, which is 84.1% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 37.55, which is 24.1% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 58.74.